NEW YORK (Reuters) - Crohn's disease patients taking Johnson & Johnson's Remicade either alone or with azathioprine experienced steroid-free remission in significantly greater numbers than those ...
Phase 3 data show treatment with REMICADE® (infliximab) resulted in rapid, significant improvement and long-term response in patients with moderate to severe plaque psoriasis. Findings from the ...
HORSHAM, PA and KENILWORTH, NJ, NOVEMBER 6, 2007—Centocor, Inc., Schering-Plough Corporation, and Mitsubishi Tanabe Pharma Corporation announced today that an estimated one million patients have now ...
MALVERN, Pa. and KENILWORTH, N.J., Oct. 6 /PRNewswire-FirstCall/ -- Centocor, Inc. and Schering-Plough Corporation today announced that the European Commission has ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients with Crohn’s disease who were biologic naive ...
A group of independent FDA advisers voted in favor of OK'ing Pfizer ($PFE) and Celltrion's take on the blockbuster inflammation treatment Remicade for all of the ...
The FDA has approved Remicade from Janssen Biotech to treat moderately to severely active ulcerative colitis in children over age 6 who responded inadequately to conventional therapy, according to an ...
NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.
WASHINGTON - Patients taking Remicade for rheumatoid arthritis suffered a type of cancer, lymphoma, at three times the rate of the general public, manufacturer Centocor warned doctors Thursday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback